The Lancet Oncology in conversation with
By The Lancet Group
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by The Lancet Group
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 13
Reviews: 0
Episodes: 196
Description
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
| Episode | Date |
|---|---|
|
James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean
|
Apr 29, 2024 |
|
Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials
|
Apr 08, 2024 |
|
Maria Kyrgiou on innovations in gynaecological cancers and global disparities
|
Mar 07, 2024 |
|
Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers
|
Feb 26, 2024 |
|
Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer
|
Jan 29, 2024 |
|
Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma
|
Jan 02, 2024 |
|
Neerja Bhatla on a new quadrivalent HPV vaccine
|
Nov 29, 2023 |
|
Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery
|
Nov 01, 2023 |
|
Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma
|
Oct 31, 2023 |
|
Wanda Cui on measuring ovarian toxicity
|
Oct 03, 2023 |
|
Ticiana Leal on Tumour Treating Fields
|
Sep 01, 2023 |
|
Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA
|
Aug 02, 2023 |
|
Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma
|
Jul 03, 2023 |
|
Madeline Pe on the SISAQOL initiative
|
May 31, 2023 |
|
Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children
|
May 02, 2023 |
|
Mark Lythgoe on UK oncology drug approval after Brexit
|
Mar 27, 2023 |
|
Janet Brown on the phase 2/3 STAR trial
|
Feb 28, 2023 |
|
Valerie Speirs on biomarkers in male breast cancer
|
Jan 30, 2023 |
|
Sameer Bakhshi on sex disparities in childhood cancer in India
|
Jan 03, 2023 |
|
Shankar Siva on radiotherapy for primary renal cell carcinoma
|
Nov 28, 2022 |
|
Mark Lawler and Richard Sullivan on the European Groundshot
|
Nov 15, 2022 |
|
Samar Alhomoud on challenges for cancer control in the Gulf region
|
Oct 31, 2022 |
|
Inge Marie Svane on mRNA vaccines for cancer treatment
|
Sep 27, 2022 |
|
Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer
|
Aug 30, 2022 |
|
Ignace Vergote and Maria Kyrgiou on gynaecological cancers
|
Jul 25, 2022 |
|
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer
|
Jun 30, 2022 |
|
Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr on cancer in sub-Saharan Africa
|
May 09, 2022 |
|
Georgios Lyratzopoulos on emergency presentation
|
Apr 28, 2022 |
|
Lisa Iezzoni on disabilities and cancer, and Jordan Marchak on mental health problems in young cancer survivors
|
Mar 29, 2022 |
|
Rosie Bradley on early-stage breast cancer treatment
|
Feb 28, 2022 |
|
Yi-Long Wu and Caicun Zhou on non-small-cell lung cancer
|
Feb 01, 2022 |
|
Rebecca Fitzgerald on Barrett's oesophagus surveillance
|
Jan 31, 2022 |
|
Elysia Alvarez on adolescent and young adult cancer
|
Dec 29, 2021 |
|
Aju Mathew on cancer care in India
|
Nov 29, 2021 |
|
David Pinato on cancer patients who recovered from SARS-CoV-2 infection
|
Nov 04, 2021 |
|
James Glasbey on the effect of lockdowns on cancer surgery
|
Nov 01, 2021 |
|
Manju Sengar and Christopher Booth on essential cancer drugs
|
Sep 27, 2021 |
|
Susannah Stanway, Richard Cowan, Danielle Rodin, and Miriam Mutebi on helping with cancer control in LMICs
|
Aug 31, 2021 |
|
Harriet Rumgay on the burden of cancer attributable to alcohol
|
Jul 30, 2021 |
|
Rafael Cardoso and Hermann Brenner on colorectal cancer
|
Jun 28, 2021 |
|
Takayuki Yoshino on the DESTINY-CRC01 trial
|
Jun 01, 2021 |
|
Roberto Orecchia on the ELIOT trial
|
Apr 28, 2021 |
|
Hedvig Hricak, Andrew Scott, Rifat Atun, and May Abdel-Wahab on nuclear medicine
|
Mar 31, 2021 |
|
Ariana Znaor on breast and cervical cancer in the former Soviet Union
|
Mar 01, 2021 |
|
Sathira Perera on global cancer surgery
|
Jan 21, 2021 |
|
Short-course radiotherapy for advanced rectal cancer
|
Jan 04, 2021 |
|
The crucial role of oncology nurses in cancer care
|
Nov 16, 2020 |
|
The effect of climate change on cancer control
|
Nov 02, 2020 |
|
Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer
|
Sep 29, 2020 |
|
Peptide receptor radionuclide therapy for neuroendocrine tumours
|
Sep 05, 2020 |
|
Larotrectinib in patients with TRK fusion-positive solid tumours
|
Apr 07, 2020 |
|
The future of radiotheranostics
|
Mar 11, 2020 |
|
International standards for the analysis of patient-reported outcomes in cancer trials
|
Mar 03, 2020 |
|
Presenting symptoms of cancer and stage at diagnosis
|
Jan 09, 2020 |
|
Global public and philanthropic investment in childhood cancer research
|
Dec 04, 2019 |
|
Cervical cancer in India
|
Oct 30, 2019 |
|
Oropharyngeal squamous cell carcinoma
|
Oct 03, 2019 |
|
Cancer in small island nations
|
Sep 03, 2019 |
|
Advances in radioimmunotherapy
|
Aug 29, 2019 |
|
International Neoadjuvant Melanoma Consortium
|
Jul 02, 2019 |
|
IMWG consensus on imaging in plasma cell disorders
|
May 29, 2019 |
|
Digital oncology
|
May 16, 2019 |
|
Choosing Wisely India
|
Apr 02, 2019 |
|
Paediatric vertebral radiotherapy
|
Mar 05, 2019 |
|
Malignant plural mesothelioma
|
Feb 02, 2019 |
|
CAR T-cell therapy
|
Jan 03, 2019 |
|
Cervical cancer screening in older women
|
Nov 29, 2018 |
|
Palliative care in oncology
|
Oct 19, 2018 |
|
Global review of cancer control
|
Sep 27, 2018 |
|
Are patient reported outcomes consistent?
|
Aug 31, 2018 |
|
Changing incidence of adolescent cancer
|
Aug 31, 2018 |
|
Diffuse intrinsic pontine glioma
|
Aug 14, 2018 |
|
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer
|
Jun 30, 2018 |
|
Gender and cancer immunotherapy efficacy
|
Jun 01, 2018 |
|
PROs in regulatory decision making
|
Apr 25, 2018 |
|
Vulvar field resection
|
Mar 29, 2018 |
|
Chromatin organisation and cancer prognosis
|
Mar 01, 2018 |
|
Trial design for brain metastases: The Lancet Oncology: Jan 2018
|
Dec 30, 2017 |
|
Lung cancer screening: The Lancet Oncology: November 27, 2017
|
Nov 28, 2017 |
|
Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017
|
Nov 01, 2017 |
|
Cancer in Peru: The Lancet Oncology
|
Sep 28, 2017 |
|
Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017
|
Sep 02, 2017 |
|
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
|
Jul 26, 2017 |
|
Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017
|
Jun 29, 2017 |
|
EANO and palliative care: The Lancet Oncology: June 2, 2017
|
Jun 03, 2017 |
|
Head and neck cancer Series: The Lancet Oncology: April 26, 2017
|
Apr 26, 2017 |
|
18F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017
|
Mar 30, 2017 |
|
Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017
|
Mar 02, 2017 |
|
Genomic modelling for radiation dosage: The Lancet Oncology: Feb 1 2017
|
Feb 02, 2017 |
|
Cancer survivorship in the USA: The Lancet Oncology: 30 December
|
Dec 30, 2016 |
|
Non-small cell lung cancer: The Lancet Oncology and The Lancet Respiratory Medicine: November 4, 2016
|
Nov 05, 2016 |
|
Quality of life and low-grade glioma: The Lancet Oncology: 31 October, 2016
|
Oct 31, 2016 |
|
Renal surveillance: The Lancet Oncology: August 30, 2016
|
Sep 01, 2016 |
|
Multiple myeloma: The Lancet Oncology: July 26, 2016
|
Jul 27, 2016 |
|
HPV vaccination in Japan: The Lancet Oncology: June 28, 2016
|
Jun 30, 2016 |
|
Antibody-drug conjugates for cancer therapy: The Lancet Oncology: June 01, 2016
|
Jun 02, 2016 |
|
Ethical issues in paediatric oncology trials: The Lancet Oncology: April 26, 2016
|
Apr 27, 2016 |
|
Medulloblastoma: The Lancet Oncology: March 11, 2016
|
Mar 12, 2016 |
|
NAB-paclitaxel and breast cancer: The Lancet Oncology: February 8, 2016
|
Feb 11, 2016 |
|
Rare cancers: The Lancet Oncology | February 2, 2016
|
Feb 03, 2016 |
|
Mantle-cell lymphoma: The Lancet Oncology: January 2016
|
Dec 24, 2015 |
|
Neuro-oncology: The Lancet Oncology, November 2015
|
Nov 02, 2015 |
|
Metastatic breast cancer: The Lancet Oncology: Sept 10, 2015
|
Sep 10, 2015 |
|
Breast cancer: The Lancet Oncology: Aug 6, 2015
|
Aug 11, 2015 |
|
Watchful waiting for patients with rectal cancer: The Lancet Oncology: July 6, 2015
|
Jul 07, 2015 |
|
HPV vaccine dosing schedules: The Lancet Oncology: June 10, 2015
|
Jun 10, 2015 |
|
RANO Group: The Lancet Oncology: May 28, 2015
|
May 28, 2015 |
|
HPV and cancer: The Lancet Oncology: April 30, 2015
|
Apr 30, 2015 |
|
Advances in cancer drug development: The Lancet Oncology: March 18, 2015
|
Mar 18, 2015 |
|
The Lancet Oncology: March 02, 2015
|
Mar 02, 2015 |
|
The Lancet Oncology: January 16, 2015
|
Jan 18, 2015 |
|
The Lancet Oncology: December 16, 2014
|
Dec 17, 2014 |
|
The Lancet Oncology: November 24, 2014
|
Nov 24, 2014 |
|
The Lancet Oncology: October 27, 2014
|
Oct 27, 2014 |
|
The Lancet Oncology: September 17, 2014
|
Sep 17, 2014 |
|
The Lancet Oncology: August 28, 2014
|
Aug 28, 2014 |
|
The Lancet Oncology: July 07, 2014
|
Jul 07, 2014 |
|
The Lancet Oncology: June 30, 2014
|
Jun 30, 2014 |
|
The Lancet Oncology: May 27, 2014
|
May 27, 2014 |
|
The Lancet Oncology: May 05, 2014
|
May 05, 2014 |
|
The Lancet Oncology: May 02, 2014
|
May 02, 2014 |
|
The Lancet Oncology: March 19, 2014
|
Mar 19, 2014 |
|
The Lancet Oncology: February 07, 2014
|
Feb 07, 2014 |
|
The Lancet Oncology: January 14, 2014
|
Jan 14, 2014 |
|
The Lancet Oncology: December 05, 2013
|
Dec 05, 2013 |
|
The Lancet Oncology: November 11, 2013
|
Nov 11, 2013 |
|
The Lancet Oncology: October 14, 2013
|
Oct 14, 2013 |
|
The Lancet Oncology: September 02, 2013
|
Sep 02, 2013 |
|
The Lancet Oncology: July 10, 2013
|
Jul 10, 2013 |
|
The Lancet Oncology: June 07, 2013
|
Jun 07, 2013 |
|
The Lancet Oncology: May 15, 2013
|
May 15, 2013 |
|
The Lancet Oncology: April 26, 2013
|
Apr 26, 2013 |
|
The Lancet Oncology: April 16, 2013
|
Apr 16, 2013 |
|
The Lancet Oncology: April 03, 2013
|
Apr 03, 2013 |
|
The Lancet Oncology: February 20, 2013
|
Feb 20, 2013 |
|
The Lancet Oncology: January 25, 2013
|
Jan 26, 2013 |
|
The Lancet Oncology: December 04, 2012
|
Dec 04, 2012 |
|
The Lancet Oncology: November 14, 2012
|
Nov 14, 2012 |
|
The Lancet Oncology: October 30, 2012
|
Oct 30, 2012 |
|
The Lancet Oncology: August 23, 2012
|
Aug 23, 2012 |
|
The Lancet Oncology: August 06, 2012
|
Aug 06, 2012 |
|
The Lancet Oncology: July 13, 2012
|
Jul 13, 2012 |
|
The Lancet Oncology: June 06, 2012
|
Jun 06, 2012 |
|
The Lancet Oncology: May 01, 2012
|
May 01, 2012 |
|
The Lancet Oncology: March 23, 2012
|
Mar 23, 2012 |
|
The Lancet Oncology: February 22, 2012
|
Feb 22, 2012 |
|
The Lancet Oncology: February 10, 2012
|
Feb 10, 2012 |
|
The Lancet Oncology: January 30, 2012
|
Jan 30, 2012 |
|
The Lancet Oncology: November 25, 2011
|
Nov 25, 2011 |
|
The Lancet Oncology: November 14, 2011
|
Nov 14, 2011 |
|
The Lancet Oncology: October 28, 2011
|
Oct 28, 2011 |
|
The Lancet Oncology: September 30, 2011
|
Sep 30, 2011 |
|
The Lancet Oncology: September 26, 2011
|
Sep 26, 2011 |
|
The Lancet Oncology: August 26, 2011
|
Aug 26, 2011 |
|
The Lancet Oncology: July 29, 2011
|
Jul 29, 2011 |
|
The Lancet Oncology: June 24, 2011
|
Jun 24, 2011 |
|
The Lancet Oncology: May 27, 2011
|
May 27, 2011 |
|
The Lancet Oncology: April 29, 2011
|
Apr 29, 2011 |
|
The Lancet Oncology: April 01, 2011
|
Apr 01, 2011 |
|
The Lancet Oncology: March 01, 2011
|
Mar 01, 2011 |
|
The Lancet Oncology: January 31, 2011
|
Jan 31, 2011 |
|
The Lancet Oncology: December 30, 2010
|
Dec 30, 2010 |
|
The Lancet Oncology: November 29, 2010
|
Nov 29, 2010 |
|
The Lancet Oncology: November 01, 2010
|
Nov 01, 2010 |
|
The Lancet Oncology: October 04, 2010
|
Oct 04, 2010 |
|
The Lancet Oncology: September 01, 2010
|
Sep 01, 2010 |
|
The Lancet Oncology: August 02, 2010
|
Aug 02, 2010 |
|
The Lancet Oncology: July 05, 2010
|
Jul 05, 2010 |
|
The Lancet Oncology: June 01, 2010
|
Jun 01, 2010 |
|
The Lancet Oncology: April 29, 2010
|
Apr 29, 2010 |
|
The Lancet Oncology: March 29, 2010
|
Mar 29, 2010 |
|
The Lancet Oncology: March 01, 2010
|
Mar 01, 2010 |
|
The Lancet Oncology: February 01, 2010
|
Feb 01, 2010 |
|
The Lancet Oncology: January 06, 2010
|
Jan 06, 2010 |
|
The Lancet Oncology: December 01, 2009
|
Dec 01, 2009 |
|
The Lancet Oncology: October 29, 2009
|
Oct 29, 2009 |
|
The Lancet Oncology: September 28, 2009
|
Sep 28, 2009 |
|
The Lancet Oncology: August 27, 2009
|
Aug 27, 2009 |
|
The Lancet Oncology: July 29, 2009
|
Jul 29, 2009 |
|
The Lancet Oncology: July 01, 2009
|
Jul 01, 2009 |
|
The Lancet Oncology: May 28, 2009
|
May 28, 2009 |
|
The Lancet Oncology: April 29, 2009
|
Apr 29, 2009 |
|
The Lancet Oncology: March 30, 2009
|
Mar 30, 2009 |
|
The Lancet Oncology: March 05, 2009
|
Mar 05, 2009 |
|
The Lancet Oncology: January 30, 2009
|
Jan 30, 2009 |
|
The Lancet Oncology: December 23, 2008
|
Dec 23, 2008 |
|
The Lancet Oncology: November 26, 2008
|
Nov 26, 2008 |
|
The Lancet Oncology: October 28, 2008
|
Oct 28, 2008 |
|
The Lancet Oncology: October 01, 2008
|
Oct 01, 2008 |
|
The Lancet Oncology: August 26, 2008
|
Aug 26, 2008 |
|
The Lancet Oncology: August 11, 2008
|
Aug 11, 2008 |
|
The Lancet Oncology: June 30, 2008
|
Jun 30, 2008 |
|
The Lancet Oncology: June 09, 2008
|
Jun 09, 2008 |
|
The Lancet Oncology: April 30, 2008
|
Apr 30, 2008 |
|
The Lancet Oncology: March 26, 2008
|
Mar 26, 2008 |
|
The Lancet Oncology: February 25, 2008
|
Feb 25, 2008 |